Genome modification in human embryonic stem cells

Induced pluripotent stem cell (iPSC) technology has emerged as the most promising method for generating patient‐specific human embryonic stem (ES) cells and adult stem cells (Takahashi et al., 2007, Cell 131:861–872; Wernig et al., 2007 , Nature 448:318–324; Park et al., 2008, Nature 451:141–146). So far, most studies of direct reprogramming have been done by using lentiviruses/retroviruses encoding the reprogramming factors. This represents a major limitation to therapeutic applications since viral integration in the host genome increases the risk of tumorigenicity, and low‐level residual expression of reprogramming factors may alter the differentiation potential of the human iPSCs (hiPSCs). As a result, more attention has been paid to developing new techniques to manipulate the human genome, with the goal of making safer hiPSCs that have fewer or no lesions or alterations in the genome. Additionally, the efficiency of reprogramming and of homologous recombination in gene therapy must be improved, if iPSC technology is to be a viable tool in regenerative medicine. Here, we summarize the recent developments in human genome manipulation for generating hiPSCs and advances in homologous recombination for gene targeting. J. Cell. Physiol. 222: 278–281, 2010. © 2009 Wiley‐Liss, Inc.

[1]  A. Bradley,et al.  Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon , 2009, Nature Methods.

[2]  Eric C. Olivares,et al.  Integration specificity of phage phiC31 integrase in the human genome. , 2006, Journal of molecular biology.

[3]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[4]  T. Fitzgerald,et al.  Induction of KLF4 in basal keratinocytes blocks the proliferation–differentiation switch and initiates squamous epithelial dysplasia , 2005, Oncogene.

[5]  C. Pabo,et al.  Design and selection of novel Cys2His2 zinc finger proteins. , 2001, Annual review of biochemistry.

[6]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[7]  V. Najfeld,et al.  Novel integrase-defective lentiviral episomal vectors for gene transfer. , 2004, Human gene therapy.

[8]  K. Hochedlinger,et al.  Guidelines and techniques for the generation of induced pluripotent stem cells. , 2008, Cell stem cell.

[9]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[10]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[11]  C. Stewart,et al.  Derivation of embryonic stem cell lines. , 1993, Methods in enzymology.

[12]  Rudolf Jaenisch,et al.  Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors , 2009, Cell.

[13]  M. Schuldiner,et al.  Modeling for Lesch‐Nyhan Disease by Gene Targeting in Human Embryonic Stem Cells , 2004, Stem cells.

[14]  Martin Pera,et al.  A method for genetic modification of human embryonic stem cells using electroporation , 2007, Nature Protocols.

[15]  Y. Liu,et al.  Creation of Engineered Human Embryonic Stem Cell Lines Using phiC31 Integrase , 2008, Stem cells.

[16]  H. Varmus,et al.  Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection , 1996, Journal of virology.

[17]  Rudolf Jaenisch,et al.  Ectopic Expression of Oct-4 Blocks Progenitor-Cell Differentiation and Causes Dysplasia in Epithelial Tissues , 2005, Cell.

[18]  G. Keller,et al.  Identification and targeting of the ROSA26 locus in human embryonic stem cells , 2007, Nature Biotechnology.

[19]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[20]  J. Mcwhir,et al.  Sequential genetic modification of the hprt locus in human ESCs combining gene targeting and recombinase-mediated cassette exchange. , 2008, Cloning and stem cells.

[21]  S. E. Barker,et al.  Effective gene therapy with nonintegrating lentiviral vectors , 2006, Nature Medicine.

[22]  J. Bitinaite,et al.  FokI dimerization is required for DNA cleavage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Chad A. Cowan,et al.  Derivation of embryonic stem-cell lines from human blastocysts. , 2004, The New England journal of medicine.

[24]  Chad A. Cowan,et al.  A high-efficiency system for the generation and study of human induced pluripotent stem cells. , 2008, Cell stem cell.

[25]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[26]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[27]  M. Capecchi,et al.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.

[28]  K. Woltjen,et al.  Virus free induction of pluripotency and subsequent excision of reprogramming factors , 2009, Nature.

[29]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[30]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[31]  V. Nair.  Retrovirus-induced oncogenesis and safety of retroviral vectors. , 2008, Current opinion in molecular therapeutics.

[32]  Dana Carroll,et al.  Gene targeting using zinc finger nucleases , 2005, Nature Biotechnology.

[33]  R. Plasterk,et al.  Molecular Reconstruction of Sleeping Beauty , a Tc1-like Transposon from Fish, and Its Transposition in Human Cells , 1997, Cell.

[34]  M. Schuldiner,et al.  Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells , 2001, Current Biology.

[35]  J. Mallet,et al.  Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo , 2006, Proceedings of the National Academy of Sciences.

[36]  E. Stanley,et al.  Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. , 2008, Blood.

[37]  T. Cantz,et al.  Induced pluripotent stem cells generated without viral integration , 2009, Hepatology.

[38]  Min Han,et al.  Efficient Transposition of the piggyBac (PB) Transposon in Mammalian Cells and Mice , 2005, Cell.

[39]  James A. Thomson,et al.  Homologous recombination in human embryonic stem cells , 2003, Nature Biotechnology.

[40]  Xiao-Jin Yu,et al.  Transient gene expression by nonintegrating lentiviral vectors. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[41]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[42]  Prashant Mali,et al.  Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. , 2009, Cell stem cell.

[43]  Jonathan L. Linehan,et al.  Efficient and Stable Transgene Expression in Human Embryonic Stem Cells Using Transposon‐Mediated Gene Transfer , 2007, Stem cells.

[44]  Luigi Naldini,et al.  Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery , 2007, Nature Biotechnology.

[45]  Ronnie J Winfrey,et al.  Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. , 2008, Molecular cell.

[46]  David Baltimore,et al.  Chimeric Nucleases Stimulate Gene Targeting in Human Cells , 2003, Science.

[47]  J A Thomson,et al.  Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. , 2000, Developmental biology.